Results 291 to 300 of about 1,005,431 (399)

Intact Proteoform Analysis by Capillary Electrophoresis–Mass Spectrometry. Are We There Yet?

Angewandte Chemie, EarlyView.
Mass spectrometry (MS) and top–down proteomics (TDP) have emerged as powerful tools to decipher proteoform‐level information, advancing biological insight and translational research. This study unites leaders in capillary electrophoresis (CE) and MS from multiple institutions across the globe to showcase the reproducibility, unique information, and ...
Noah Gould, Qianjie Wang, Jeffrey N. Agar, Jennifer S. Brodbelt, Daoyang Chen, Kellye A. Cupp‐Sutton, Elena Domínguez‐Vega, Fei Fang, Marianne Fillet, Matthew S Fischer, Attila Gaspar, Ying Ge, Marie‐Jia Gou, Michal Greguš, Christoph Gstöttner, Narmin Hamidli, Amanda Helms, Md Amin Hossain, Kyle J. Juetten, Neil L. Kelleher, Tobias Kraus, Eli J. Larson, J. Scott Mellors, Cynthia Nagy, Christian Neusüß, Erin A. Redman, Jasmin Schairer, Si Wu, Tian Xu, Zhitao Zhao, Guijie Zhu, Alexander R. Ivanov, Kevin Jooß, Liangliang Sun   +33 more
wiley   +2 more sources

Control of Shigella sonnei and adhesive invasive Escherichia coli infections with a natural product which inhibits the bacterial oxidoreductase DsbA

, 2017
Zainulabedeen R. M. H. Mirza
openalex   +1 more source

Unnatural Amino Acid and Emerging Chemistry Approaches to Map RNA–Protein Interactions

Angewandte Chemie, EarlyView.
This review highlights emerging chemistries for mapping RNA–protein interactions, including genetically encoded unnatural amino acids, novel photocrosslinkers, and non‐photoactivatable crosslinking systems. We compare their mechanisms, reactivity and applications, outlining how these next‐generation tools enable higher‐resolution, site‐specific ...
Eryn Lundrigan, Parrish Evers, Elexa Scott, John Paul Pezacki   +3 more
wiley   +2 more sources

Inactivation of the Burkholderia Toxin Malleicyprol by Enzymatic Cyclopropanol Ring Opening

Angewandte Chemie, EarlyView.
Burkholderia pseudomallei and Burkholderia mallei are dangerous pathogens that cause severe diseases with high mortality rates. Their virulence relies in part on malleicyprols, potent toxins containing a highly reactive cyclopropanol group. In this study, we identify BurK, a heme‐dependent oxidoreductase that neutralizes malleicyprols by enzymatically ...
Jonas Fiedler, Ingrid Richter, Katharina Dornblut, Alicia Scharf, Christian Hertweck   +4 more
wiley   +2 more sources

Risk Factors For and Outcomes of Multidrug-Resistant Escherichia coli Infections in Children. [PDF]

Infect Dis Ther, 2017
Uzodi AS, Lohse CM, Banerjee R.
europepmc   +1 more source

Evaluation of the molecular epidemiology of ESBL-producing Escherichia coli associated with blood stream infections in China

, 2017
Olsson Anna
openalex   +1 more source

Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

Journal of Infectious Diseases, 2005
J. Brooks, E. Sowers, J. Wells, K. Greene, P. Griffin, R. Hoekstra, N. Strockbine   +6 more
semanticscholar   +1 more source

Heteromultivalent Nanogels as Highly Potent Inhibitors of Pseudomonas Aeruginosa

Angewandte Chemie International Edition, EarlyView.
A heteromultivalent polyglycerol nanogel system integrates fucose/galactose and short‐chain antibacterial peptides to achieve strong bactericidal and anti‐biofilm effects at low concentration by efficient multivalent binding with bacterial lectins.
Yuhang Jiang, Chuanxiong Nie, Boyu Zheng, Vinod Khatri, Denis Puccio, Yanping Long, Mathias Dimde, Rainer Haag, Sumati Bhatia   +8 more
wiley   +1 more source

Group B Streptococcus and Escherichia coli Infections in the Intensive Care Nursery in the Era of Intrapartum Antibiotic Prophylaxis

The Pediatric Infectious Disease Journal, 2012
Melissa S. Bauserman, M. Laughon, Christoph P. Hornik, P. B. Smith, Daniel K. Benjamin, Reese H. Clark, Cyril Engmann, M. Cohen-Wolkowiez   +7 more
semanticscholar   +1 more source

Quinolones and fluoroquinolones are useless to counter uropathogenic Escherichia coli infections [Letter]. [PDF]

Infect Drug Resist, 2019
Singh BR.
europepmc   +1 more source